Targeted Photodynamic Therapy using a Vectorized Photosensitizer coupled to Folic Acid Analog induces Ovarian Tumor Cell Death and inhibits IL-6-mediated Inflammation

Léa Boidin,Morgane Moinard,Albert Moussaron,Margaux Merlier,Olivier Moralès,Guillaume Paul Grolez,Martha Baydoun,Amirah Mohd-Gazzali,Mohammad Hafizie Dianel Mohd Tazizi,Hassan Hadi Abd Allah,Yohan Kerbage,Philippe Arnoux,Samir Acherar,Céline Frochot,Nadira Delhem
DOI: https://doi.org/10.1016/j.jconrel.2024.05.033
IF: 11.467
2024-06-08
Journal of Controlled Release
Abstract:Ovarian cancer (OC) is one of the most lethal cancers among women. Frequent recurrence in the peritoneum due to the presence of microscopic tumor residues justifies the development of new therapies. Indeed, our main objective is to develop a targeted photodynamic therapy (PDT) treatment of peritoneal carcinomatosis from OC to improve the life expectancy of cancer patients. Herein, we propose a targeted-PDT using a vectorized photosensitizer (PS) coupled with a newly folic acid analog (FAA), named PS FAA , in order to target folate receptor alpha (FRα) overexpressed on peritoneal metastasis. This PS FAA was the result of the coupling of pyropheophorbide- a (Pyro- a ), as the PS, to a newly synthesized FAA via a polyethylene glycol (PEG) spacer. The selectivity and the PDT efficacy of PS FAA was evaluated on two human OC cell lines overexpressing FRα compared to fibrosarcoma cells underexpressing FRα. Final PS FAA , including the synthesis of a newly FAA and its conjugation to Pyro- a , was obtained after 10 synthesis steps, with an overall yield of 19%. Photophysical properties of PS FAA in EtOH were performed and showed similarity with those of free Pyro- a , such as the fluorescence and singlet oxygen quantum yields (Φ f = 0.39 and Φ Δ = 0.53 for free Pyro- a , and Φ f = 0.26 and Φ Δ = 0.41 for PS FAA ). Any toxicity of PS FAA was noticed. After light illumination, a dose-dependent effect on PS concentration and light dose was shown. Furthermore, a PDT efficacy of PS FAA on OC cell secretome was detected inducing a decrease of a pro-inflammatory cytokine secretion (IL-6). This new PS FAA has shown promising biological properties highlighting the selectivity of the therapy opening new perspectives in the treatment of a cancer in a therapeutic impasse.
pharmacology & pharmacy,chemistry, multidisciplinary
What problem does this paper attempt to address?